Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment

Journal of Glaucoma

Volumn 18, Issue 3, 2009, Pages 197-200

  Rodrigues, Maria De Lourdes Veronese ^a,c   Felipe Crosta, Daniela Pereira Da Silva ^a   Soares, Christiane Pienna ^b   Deghaide, Neifi Hassam Saloum ^a   Duarte, Roberta ^b   Sakamoto, Fabiano S ^a   Furtado, João Marcello Fortes ^a   Paula, Jayter Silva ^a   Donadi, Eduardo Antonio ^a   Soares, Edson Garcia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c NONE   (Brazil)

Author keywords

Conjunctival in.ammation; Glaucoma treatment; HLA DR; Prostaglandin analog

Indexed keywords

BIMATOPROST; HLA DR ANTIGEN; LATANOPROST; TRAVOPROST; AMIDE; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; CLOPROSTENOL; DRUG DERIVATIVE; PROSTAGLANDIN F;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMIDES; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; CLOPROSTENOL; CONJUNCTIVITIS; FEMALE; GLAUCOMA, OPEN-ANGLE; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROSTAGLANDINS F, SYNTHETIC;

EID: 65649136930     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31818153f4     Document Type: Article

References (16)

1. Stewart WC, Stewart JA, Jenkins JN, et al. Corneal punctate staining with latanoprost, bimatoprost and travoprost in healthy subjects. J Glaucoma. 2003;12:475-479. (Pubitemid 37494175)
2. Stewart WC, Kolker AE, Stewart JA, et al. Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost. Am J Ophthalmol. 2005;135:314-320.
3. Hong S, Lee CS, Seo KY, et al. Effects of topical antiglaucoma application on conjunctival impression cytology specimens. Am J Ophthalmol. 2006;142:185-186. (Pubitemid 43946804)
4. Cvnkel B, Ihan A. Ocular surface changes induced by topical antiglaucoma monotherapy. Ophthalmologica. 2002;216:175-179. (Pubitemid 34639068)
5. Guglielminetti E, Barabino S, Monaco M, et al. HLA-DR expression in conjunctival cells after latanoprost. J Ocul Pharmacol Ther. 2002;18:1-9. (Pubitemid 34132688)
6. Pisella PJ, Debbasch C, Hamard P, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci. 2004;45:1360-1368. (Pubitemid 38859312)
7. Baudouin C, Liang H, Hamard P, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology. 2008;115:109-115.
8. Nuzzi R, Vercelli A, Finazzo C, et al. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol. 1995;233: 154-162.
9. Ihan A, Cvenkel B. Conjunctival epithelium expression of HLA-DR in glaucoma patients and its influence on the outcome of filtration surgery. Br J Ophthalmol. 2000;84: 648-650. (Pubitemid 30339321)
10. Baudouin C, Hamard P, Liang H, et al. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology. 2004;111:2186-2192. (Pubitemid 39575587)
11. Tsironi S, Ioachim E, Machera M, et al. Immunohistochemical HLA-DR antigen expression with lymphocyte subsets and proliferative activity in pterygium. In vivo. 2002;16:299-306. (Pubitemid 35460380)
12. Broadway DC, Grierson I, Sturmer J, et al. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol. 1996;114:262-267. (Pubitemid 26086730)
13. Voltarelli JC. Mecanismos imunológicos das doenças oculares. In: Rodrigues MLV, Dantas AM, eds. Oftalmologia Clínica. Rio de Janeiro: Cultura Médica; 2001:459-466.
14. Genoun JM, Baudouin C, Rat P, et al. In vitro study of inflammatory potential and toxicity profile of latano prost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005;46: 2444-2450. (Pubitemid 43119492)
15. Pisella PJ. Conjunctival markers as predictable markers for preoperative glaucoma assessment (editorial). Br J Ophthalmol. 2006;90:1335-1336.
16. Souchier M, Buron N, Lafontaine PO, et al. Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery? Br J Ophthalmol. 2006;90:1366-1369. (Pubitemid 44702061)